{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:34:54Z","timestamp":1788287694296,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbi.2025.106233","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:21:40Z","timestamp":1766118100000},"page":"106233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Can the COVID-19 pandemic advance neuroinfectious research?"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-4423","authenticated-orcid":false,"given":"Michael R.","family":"Duggan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena K.","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia A.","family":"Auber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Silberberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki M.","family":"Schultek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.106233_b0005","first-page":"6","article-title":"The Extended Impact of Human Immunodeficiency Virus\/AIDS Research","volume":"219","author":"Schwetz","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbi.2025.106233_b0010","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies","volume":"10","author":"Trickey","year":"2023","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.bbi.2025.106233_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.respol.2024.105076","article-title":"Research-targeting, spillovers, and the direction of science: evidence from HIV research-funding","volume":"53","author":"Yaqub","year":"2024","journal-title":"Res. Policy"},{"key":"10.1016\/j.bbi.2025.106233_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7861\/clinmed.ed.23.2.harv","article-title":"Pandemic HIV and its legacy for medicine and global health","volume":"23","author":"Johnson","year":"2023","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.bbi.2025.106233_b0025","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32834f33e8","article-title":"mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients","volume":"26","author":"Van Gulck","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2025.106233_b0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2025.106233_b0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2025.106233_b0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-220717","article-title":"Association of COVID-19 with New-Onset Alzheimer\u2019s Disease","volume":"89","author":"Wang","year":"2022","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.bbi.2025.106233_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","article-title":"The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap","volume":"18","author":"Walker","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2025.106233_b0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-024-03139-y","article-title":"Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review","volume":"21","author":"Kettunen","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.106233_b0055","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","article-title":"Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic","volume":"7","author":"Rogers","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2025.106233_b0060","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1002\/alz.13076","article-title":"Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration","volume":"19","author":"Lathe","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2025.106233_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt7176","article-title":"Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration","volume":"11","author":"Duggan","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbi.2025.106233_b0070","unstructured":"Association, A.s. Congress Reaches Bipartisan Agreement on $100 Million Alzheimer\u2019s Research Funding Increase and Continued Investment in Alzheimer\u2019s Public Health Infrastructure. (2024)."},{"key":"10.1016\/j.bbi.2025.106233_b0075","article-title":"Microbes and Mental Illness: past, present, and Future","volume":"12","author":"Bransfield","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.bbi.2025.106233_b0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.bbi.2025.106233_b0085","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological Features of Covid-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2025.106233_b0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2025.106233_b0095","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","article-title":"Mapping the human genetic architecture of COVID-19","volume":"600","author":"Niemi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2025.106233_b0100","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1038\/srep04530","article-title":"Meta-Analysis of Infectious Agents and Depression","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.106233_b0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1590\/1516-4446-2017-2393","article-title":"Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials","volume":"40","author":"Raupp-Barcaro","year":"2018","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.bbi.2025.106233_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40360-020-0391-x","article-title":"Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial","volume":"21","author":"Dietrich","year":"2020","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.bbi.2025.106233_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119891","article-title":"Comparative efficacy of antidepressant augmentation with amantadine vs pramipexole in treatment-resistant unipolar depression: a randomised controlled trial","volume":"390","author":"Mishra","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.106233_b0120","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/ene.14652","article-title":"The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19","volume":"28","author":"Beghi","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbi.2025.106233_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12028-020-00995-3","article-title":"Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale","volume":"33","author":"Frontera","year":"2020","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.bbi.2025.106233_b0130","article-title":"Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium","volume":"8","author":"de Erausquin","year":"2022","journal-title":"Alzheimers Dement (n y)"},{"key":"10.1016\/j.bbi.2025.106233_b0135","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1287\/mnsc.2015.2285","article-title":"Looking across and looking beyond the Knowledge Frontier: Intellectual Distance, Novelty, and Resource Allocation in Science","volume":"62","author":"Boudreau","year":"2016","journal-title":"Manag. Sci."},{"key":"10.1016\/j.bbi.2025.106233_b0140","article-title":"Impure science: AIDS, activism, and the politics of knowledge","author":"Epstein","year":"1996","journal-title":"(univ of California Press"},{"key":"10.1016\/j.bbi.2025.106233_b0145","first-page":"627","article-title":"From advocacy to austerity: the new role of the U.S. public sector in HIV drug development and access. Glob","volume":"15","author":"Whitacre","year":"2020","journal-title":"Public Health"},{"key":"10.1016\/j.bbi.2025.106233_b0150","unstructured":"National Academies of Sciences, E. & Medicine. Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses. (2025)."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125004751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125004751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:48:41Z","timestamp":1783712921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125004751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"alternative-id":["S0889159125004751"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106233","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the COVID-19 pandemic advance neuroinfectious research?","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106233"}}